Singaporean company helps Vietnam with rare disease treatment
Shire Singapore PTE. Ltd. (Shire) will help Vietnam improve the quality of diagnosis, treatment and management of a number of rare diseases in the country for the 2018-2023 period.
Hanoi (VNA) – Shire Singapore PTE. Ltd. (Shire)will help Vietnam improve the quality of diagnosis, treatment and management ofa number of rare diseases in the country for the 2018-2023 period.
A memorandum of understanding (MoU) to this effect was signed byrepresentatives of the Medical Services Administration under Vietnam’s HealthMinistry and Shire Vietnam in Hanoi on April 20.
Under the MoU, the Singaporean company will also support Vietnam in improvingprofessional knowledge, implementing policies on rare disease management andensuring policies on rare medicine supply in the country, said Luong Ngoc Khue,Director of the Medical Services Administration.
During the first stage, the two sides will work together to develop a nationalguideline to improve the quality of diagnosis, treatment and management ofHaemophilia and Primary Immune Deficiency (PID) as well as to support policydevelopment on rare diseases in Vietnam.
Linda Seah, head of Southeast Asia Cluster at Shire, said Haemophilia and PIDare complex rare disorders that require continuous medical research andinnovative approach to ensure positive outcome for patients.
The MoU is the first of its kind for Shire in Asia Pacific, aiming not only toshorten the time for diagnosis but also ensure that patients are well supportedwith adequate access to therapy and management over the course of their life-longconditions, she said.
According to the World Health Organisation (WHO), there are approximately 100rare diseases reported in Vietnam. It is estimated that almost one in 15persons, or approximately six million people in the country, suffer from a raredisease. Vietnam has more than 6,000 haemophilia patients, but only 2,400 havebeen detected their disease situation, while PID remains common and adverselyaffects the prognosis of these patients. –VNA
A national programme for comprehensive care of hemophilia, a hereditary blood disorder, is needed, according to Dr Phu Chi Dung, Head of HCM City Blood Transfusion Hematology Hospital.
The Vietnam Students in Singapore Association organised a beauty contest on December 10 to select a representative for its charity work in the host nation.
Ensuring adequate and timely supply of medicines, especially for the prevention and treatment of rare diseases, will be the central aspect of HCM City’s Strategy on National Pharmaceutical Development
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
At the signing ceremony (Photo: VNA) 
